HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.

Abstract
Tandem repeat number polymorphism of a CCTTT pentanucleotide in the promoter region of the inducible nitric oxide synthase gene (iNOS) and a polymorphism of the interleukin-1beta (IL-1B) promoter at position -31 were analyzed in DNA samples from 181 Japanese control subjects and 158 gastric cancer patients, including 96 intestinal type and 62 diffuse type. An association between the intestinal type of gastric adenocarcinoma and higher promoter activity of the iNOS gene was found in women, especially those having higher promoter activity of the IL-1B gene and without a history of smoking. Our results imply that chronic inflammation caused by excess nitric oxide generated by iNOS contributes to Helicobacter pylori-induced gastric cancer.
AuthorsMasayuki Tatemichi, Tomohiro Sawa, Isabelle Gilibert, Hiroshi Tazawa, Takahiko Katoh, Hiroshi Ohshima
JournalCancer letters (Cancer Lett) Vol. 217 Issue 2 Pg. 197-202 (Jan 20 2005) ISSN: 0304-3835 [Print] Ireland
PMID15617837 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
  • Interleukin-1
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
Topics
  • Adenocarcinoma (genetics, pathology)
  • Aged
  • DNA, Neoplasm (analysis, genetics)
  • Female
  • Helicobacter Infections (complications, genetics)
  • Helicobacter pylori
  • Humans
  • Interleukin-1 (genetics)
  • Japan
  • Male
  • Microsatellite Repeats (genetics)
  • Middle Aged
  • Nitric Oxide Synthase (genetics)
  • Nitric Oxide Synthase Type II
  • Polymorphism, Genetic
  • Promoter Regions, Genetic (genetics)
  • Risk Factors
  • Sex Factors
  • Stomach Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: